 Lung Neoplasms
"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 16 | 5 | 21 | | 1997 | 25 | 2 | 27 | | 1998 | 13 | 2 | 15 | | 1999 | 13 | 2 | 15 | | 2000 | 16 | 1 | 17 | | 2001 | 14 | 7 | 21 | | 2002 | 38 | 8 | 46 | | 2003 | 22 | 3 | 25 | | 2004 | 33 | 4 | 37 | | 2005 | 37 | 3 | 40 | | 2006 | 38 | 9 | 47 | | 2007 | 48 | 8 | 56 | | 2008 | 39 | 7 | 46 | | 2009 | 40 | 4 | 44 | | 2010 | 53 | 3 | 56 | | 2011 | 39 | 4 | 43 | | 2012 | 60 | 5 | 65 | | 2013 | 70 | 12 | 82 | | 2014 | 74 | 9 | 83 | | 2015 | 65 | 9 | 74 | | 2016 | 84 | 8 | 92 | | 2017 | 80 | 10 | 90 | | 2018 | 91 | 10 | 101 | | 2019 | 82 | 4 | 86 | | 2020 | 79 | 6 | 85 | | 2021 | 83 | 2 | 85 | | 2022 | 92 | 1 | 93 | | 2023 | 91 | 2 | 93 | | 2024 | 57 | 5 | 62 | | 2025 | 65 | 3 | 68 | | 2026 | 29 | 2 | 31 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Fox AH, Ward RC, Alexander M, Osarogiagbon RU, Smith RA, Studts JL, Silvestri GA. Rates of Systemic Treatment for Metastatic Non-Small Cell Lung Cancer Among Older Adults. JAMA Oncol. 2026 Jul 01; 12(7):705-713.
-
Gorbatov ML, Arizpe A, David EA, Liu L, Cockburn M, Farias AJ. Racial and ethnic disparities in receipt of guideline-concordant treatment for early-stage non-small cell lung cancer. Cancer Causes Control. 2026 Jul 01; 37(7).
-
Lovly CM, Baik C, Nagasaka M, Patil T, Maruti SS, Stanhope S, Kaya NA, Herbertz S, Nordstrom B, Evans K, Le X. Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non-Small Cell Lung Cancer. JCO Precis Oncol. 2026 Jun; 10(6):e2501272.
-
Aleman JD, Young CD, Ke Y, Nguyen KA, Lu I, Goon JB, Abello AE, Lind HT, Karam SD, Birkeland AC, Wang XJ. Ectopic integrin ß1 overproduction by squamous carcinoma cells contributes to immune evasion-associated metastasis. Cancer Lett. 2026 Sep 28; 656:218635.
-
Bazhenova L, Ismaila N, Durm G, Freeman-Daily J, Horinouchi H, MacVicar GR, Mishra DR, Pellini B, Schenk EL, Singh N, Leighl NB. Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1. J Clin Oncol. 2026 06 20; 44(18):e101-e112.
-
Paez R, Khalil TA, Forero Y, Woodhouse P, Antic S, Holmes H, Fremont RD, Brandt W, Chen H, Chen SC, Kaizer A, Shojaee S, Lentz RJ, Deppen SA, Barón AE, Grogan EL, Maldonado F. Assessing a biomarker platform for stratifying indeterminate pulmonary nodules, protocol for the SPOT IT randomized trial. Trials. 2026 May 12; 27(1).
-
Drilon A, Cho BC, Camidge DR, Nagasaka M, Besse B, Solomon B, Goto K, Wolf J, Popat S, Felip E, Yang N, de Langen AJ, Lu S, Velcheti V, Lin AL, Calvet CY, Li L, Tschaika M, Afsar S, Yang H, Lin JJ. Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis. Oncologist. 2026 May 08; 31(6).
-
Lula LJ, Costa R, Franssen AJPM, Huang L, Özgür EG, Barreda CF, Domjan M, Weedle R, Jasovic C, Trabalza Marinucci B, Rebei M, Ghasemi K, Moreira AL, Ryan R, Bekiroglu GN, Young V, Gomez T, de Loos ER, Fitzmaurice GJ, Bennett KE, Mancini M, Varela G, Savu C, Mariolo AV, Bunn P, Stupnik T, Furak J, D'Andrilli A, Jimenez M, Cerfolio R, Bolca C, Brunelli A, Rami-Porta R, Petersen RH, Rendina EA. European analysis of patients with early-stage lung adenocarcinoma and invasive pathologic features who underwent lobectomy versus segmentectomy. J Thorac Cardiovasc Surg. 2026 Aug; 172(2):413-421.e4.
-
Nie Y, Staley A, Hinz TK, Perez-Johnston R, Merrick DT, Yang MC, Davies KD, Bunn PA, Aisner DL, Camidge DR, Schenk EL, Heasley LE, Patil T. High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase Inhibitors. Clin Lung Cancer. 2026 Jun; 27(5):96-105.
-
Chen NC, Zemplenyi AT, Adamson B, Kaizer AM, O'Bryant CL, McQueen RB, Anderson KE. Using Regression Discontinuity in Time to Strengthen Real-World Evidence: A Case Study in Lung Cancer. Med Decis Making. 2026 Jul; 46(5):601-623.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|